Search
Arbutus Biopharma Corp
ABUSAdd to Watchlist
4.340USD
-0.070-1.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
857.31MMarket Cap
5.23P/E TTM
ABUS Income Statement
You can find the annual or quarterly income statement of Arbutus Biopharma Corp here for insights into the performance and operational efficiency of Arbutus Biopharma Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Arbutus Biopharma Corp's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing ABUS stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Arbutus Biopharma Corp's revenue at year end?
Arbutus Biopharma Corp reported 14.08M in revenue for fiscal year 2025, up from 6.17M in the previous year.
How much revenue did Arbutus Biopharma Corp report in the most recent quarter?
Arbutus Biopharma Corp reported 179.13M in revenue for the most recent quarter, an increase of 10054.54% year over year.
What was Arbutus Biopharma Corp's net income for the year?
Arbutus Biopharma Corp posted -33.50M in net income for fiscal year 2025.
How much net income did Arbutus Biopharma Corp post in the last quarter?
Arbutus Biopharma Corp reported 169.69M in net income for the latest quarter。
What was Arbutus Biopharma Corp's annual operating profit?
Arbutus Biopharma Corp's operating income was -27.05M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.